Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Ipamorelin

NNC 26-0161, Aib-His-D-2-Nal-D-Phe-Lys-NH2

Quick Stats
Studies 17
Trials 2
Score 3
2001 pubmed

Structural similarity of ghrelin derivatives to peptidyl growth hormone secretagogues.

Matsumoto. M M; Kitajima. Y Y; Iwanami. T T; Hayashi. Y Y; Tanaka. S S; Minamitake. Y Y; Hosoda. H H; Kojima. M M; Matsuo. H H; Kangawa. K K

Key Findings

  • The N‑terminal tetrapeptide with an octanoyl group is the smallest active part of ghrelin.
  • A new short analogue (5‑aminopentanoyl‑Ser(Octyl)‑Phe‑Leu‑aminoethylamide) matches ghrelin’s activity.
  • Gly‑Ser acts as a spacer, and using D‑amino acids at positions 3‑4 changes the peptide’s shape and activity.

Practical Outcomes

  • For biohackers, this means short ghrelin‑derived peptides can be effective GH secretagogues, supporting the use of compounds like ipamorelin. It also hints that tweaking the spacer region or using D‑amino acids could fine‑tune potency, though no specific dosing advice is provided.

Summary

Scientists found that a tiny piece of the hormone ghrelin, when tweaked slightly, works just as well as the full hormone at triggering growth hormone release. This shows that very short, modified peptides can be powerful, which is useful for people looking at ghrelin‑like compounds such as ipamorelin.

Abstract

Ghrelin is a 28-amino acid residue endogenous growth hormone secretagogue. Intensive investigations revealed that the N-terminus tetrapeptide, having octanoyl group at Ser(3), is the minimum active core. In this study, we further explored the structure-function relationships of the active N-terminus portion of ghrelin using a Ca(2+) mobilization assay. The smallest and most potent ghrelin derivative we have found so far is 5-aminopentanoyl-Ser(Octyl)-Phe-Leu-aminoethylamide, showing comparable activity to the natural molecule. In the process of modifying the active core, the ghrelin-derived short analogues emerged structurally close to peptidyl growth hormone secretagogues. The N-terminus modification suggested that Gly(1)-Ser(2) unit works as a spacer, forming adequate distance between N(alpha)-amino group and n-octanoyl group. Replacement of 3rd and 4th amino acid residues to D-isomer suggested that the N-terminal dipeptide contributes to shape the biologically active geometry by effecting conformation of residues in positions 3 and 4.

Study Information

Provider

pubmed

Year

2001

Date

2001-06-15T00:00:00.000Z

DOI

10.1006/bbrc.2001.5014